Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Insulet Corp PODD

Healthcare Medical Devices
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also... see more

Recent & Breaking News (NDAQ:PODD)

Insulet Corporation Honors National Diabetes Awareness Month at the NASDAQ Stock Market Closing Bell Ceremony on November 1st

Business Wire November 1, 2016

Insulet Corporation (Nasdaq: PODD) to Ring The Nasdaq Stock Market Closing Bell

GlobeNewswire October 31, 2016

Insulet Announces Board and Management Changes

Business Wire October 19, 2016

Research Reports Coverage on Healthcare Stocks -- Antares Pharma, Insulet, Glaukos, and CR Bard

PR Newswire October 13, 2016

Insulet Corporation to Announce Third Quarter 2016 Financial Results on November 3, 2016

Business Wire September 27, 2016

Insulet Enrolls First Patients in Clinical Trial for its Omnipod® Artificial Pancreas System

Business Wire September 13, 2016

Insulet Announces Pricing of Convertible Senior Notes Due 2021

Business Wire September 7, 2016

Insulet Announces Private Offering of Convertible Senior Notes

Business Wire September 6, 2016

Insulet to Establish Highly-Automated Manufacturing Operation in the United States

Business Wire September 6, 2016

Insulet Announces Executive Appointments

Business Wire September 6, 2016

Benzinga's Volume Movers

Benzinga.com  August 4, 2016

Insulet Reports Second Quarter 2016 Financial Results

Business Wire August 3, 2016

Insulet Corporation to Present at Upcoming Investor Conferences

Business Wire August 1, 2016

BMO Capital Highlights This Week's MedTech Earnings

Benzinga.com  August 1, 2016

Insulet Launches New Educational iPad App: Toby’s T1D Tale

Business Wire July 13, 2016

Insulet Corporation to Announce Second Quarter 2016 Financial Results on August 3, 2016

Business Wire July 6, 2016

Collegium Announces Election of John A. Fallon, M.D. to Board of Directors

GlobeNewswire June 13, 2016

New Data Demonstrate Benefits of Insulet’s Omnipod® System for People with Type 1 and Type 2 Diabetes

Business Wire June 11, 2016

Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet’s Clinical Team

Business Wire June 10, 2016

Insulet to Present Omnipod® Clinical Studies on Type 1 and Type 2 Diabetes During the American Diabetes Association’s 76th Scientific Sessions

Business Wire June 8, 2016